ORAGENICS INC (OGEN) Executive Compensation
ORAGENICS INC (OGEN) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: OGEN
CIK: 1174940
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: FL
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Cherry Bekaert LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerAdam Hunter
Audit LocationTampa, Florida, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-16 | 2026-09-16 | 8-K | 0001493152-26-042843 | View SEC Doc Filr Page |
| 8-K | 2026-08-28 | 2026-08-26 | 8-K | 0001493152-26-040645 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001493152-26-037749 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-07-01 | PRIMARY DOCUMENT | 0002144116-26-000005 | View SEC Doc Filr Page |
| 3 | 2026-07-07 | 2026-07-01 | PRIMARY DOCUMENT | 0002144116-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-07-06 | 2026-06-29 | 8-K | 0001493152-26-032155 | View SEC Doc Filr Page |
| DEFA14A | 2026-05-20 | — | DEFA14A | 0001493152-26-024605 | View SEC Doc Filr Page |
| DEF 14A | 2026-05-20 | 2026-05-20 | DEF 14A | 0001493152-26-024602 | View SEC Doc Filr Page |
| 8-K | 2026-05-19 | 2026-05-18 | 8-K | 0001493152-26-024363 | View SEC Doc Filr Page |
| PRE 14A | 2026-05-08 | 2026-05-08 | PRE 14A | 0001493152-26-021969 | View SEC Doc Filr Page |
| 10-Q | 2026-05-08 | 2026-03-31 | 10-Q | 0001493152-26-021967 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0001493152-26-021627 | View SEC Doc Filr Page |
| 8-K | 2026-04-13 | 2026-04-13 | 8-K | 0001493152-26-016294 | View SEC Doc Filr Page |
| 8-K | 2026-03-31 | 2026-03-27 | 8-K | 0001493152-26-014128 | View SEC Doc Filr Page |
| EFFECT | 2026-03-20 | — | EFFECT Filing | 9999999995-26-000882 | View SEC Doc Filr Page |
| CORRESP | 2026-03-19 | — | CORRESP Filing | 0001493152-26-011693 | View SEC Doc Filr Page |
| S-3/A | 2026-03-19 | — | S-3/A | 0001493152-26-011684 | View SEC Doc Filr Page |
| 10-K | 2026-03-16 | 2025-12-31 | 10-K | 0001493152-26-010282 | View SEC Doc Filr Page |
| 8-K | 2026-03-11 | 2026-03-10 | 8-K | 0001493152-26-009682 | View SEC Doc Filr Page |
| UPLOAD | 2026-01-27 | — | UPLOAD Filing | 0000000000-26-000820 | View SEC Doc Filr Page |
| S-3 | 2026-01-22 | — | S-3 | 0001493152-26-003241 | View SEC Doc Filr Page |
| 8-K | 2026-01-22 | 2026-01-22 | 8-K | 0001493152-26-003237 | View SEC Doc Filr Page |
| 4/A | 2026-01-22 | 2025-12-11 | PRIMARY DOCUMENT | 0001382225-26-000001 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-01-21 | — | SCHEDULE 13G Filing | 0001535610-26-000018 | View SEC Doc Filr Page |
| 8-K | 2026-01-20 | 2026-01-20 | 8-K | 0001493152-26-002759 | View SEC Doc Filr Page |